The Role of AMPK Signaling in Ulcerative Colitis

Area of Science:

• Gastroenterology
• Molecular Biology
• Pharmacology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease with high recurrence and significant impact on quality of life.
• UC is recognized as a global health challenge by the WHO due to limited curative options and malignant transformation potential.
• Understanding UC pathogenesis and developing new therapies requires further investigation.

Purpose of the Study:

• To provide a comprehensive overview of AMP-activated protein kinase (AMPK) involvement in UC.
• To compile pharmacological agents that activate the AMPK signaling pathway for UC treatment.
• To deepen the understanding of AMPK's role in UC for researchers and clinicians.

Main Methods:

• Literature review of AMPK's role in UC pathogenesis.
• Compilation of studies on pharmacological agents targeting AMPK in UC.
• Analysis of AMPK-mediated biological processes in UC.

Main Results:

• AMPK is a central regulator of cellular energy homeostasis, significantly involved in UC.
• Modulating AMPK signaling impacts intestinal inflammation, epithelial barrier function, autophagy, apoptosis, and pyroptosis in UC.
• Various pharmacological interventions, including TCM components, activate AMPK pathways to benefit UC.

Conclusions:

• AMPK plays a pivotal role in the mechanisms underlying ulcerative colitis.
• Targeting AMPK signaling presents a promising therapeutic avenue for UC.
• Further research into AMPK activators can lead to novel treatment strategies for UC.